Morgan, Jw Phd

entine book

<div style=" color: rgb(0, 0, 0); font-family: Arial, Helvetica, sans-serif; font-size: 11px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; margin: 0in 0in 0pt; background-color: rgb(255, 255, 255);">            John W. Morgan, DrPH, CPH is a Professor of Epidemiology at Loma Linda University with a primary appointment in the School of Public Health and a secondary appointment in the School of Science and Technology. In 1983, Dr. Morgan joined the faculty in the School of Public Health and has participated in teaching epidemiology in the Schools of Public Health, Nursing, Pharmacy, Science and Technology, and Medicine at Loma Linda University, including teaching of Preventive Medicine Residents. Dr. Morgan has taught more than 150 courses in the principles of epidemiology, epidemiologic research, or the epidemiology of cancer. In 1995, he joined the California Cancer Registry (CCR) as the Regional Epidemiologist for the Desert Sierra Cancer Surveillance Program (DSCSP), aka Region 5 of the California Cancer Registry, serving the approximately 4.5 million residents of Inyo, Mono, Riverside, and San Bernardino Counties. In July 2009, Dr. Morgan assumed similar responsibilities for cancer assessments in Region 4 of the CCR (Central Coast Region), covering San Luis Obispo, Santa Barbara, and Ventura Counties that includes a combined population of approximately 2.8 million. In these roles, Dr. Morgan serves as an agent of the California Department of Public Health with responsibility for cancer surveillance, cancer control, and assessment of cancer concerns in the DSCSP, the Central Coast Region, and statewide.</div>

<div style=" color: rgb(0, 0, 0); font-family: Arial, Helvetica, sans-serif; font-size: 11px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; margin: 0in 0in 0pt; text-indent: 0.5in; background-color: rgb(255, 255, 255);">Since Dr. Morgan joined the CCR in 1995 as the Regional Cancer Epidemiologist, he has authored or co-authored 40 peer-reviewed scientific publications or reports, conducted hundreds of community and media interviews or presentations that dispense cancer control and prevention information, established and enlarged collaborations with the American Cancer Society (ACS) Loma Linda University School of Public Health, and other public health, academic, healthcare, and community-based organizations involved in cancer control. In this capacity, Dr. Morgan has developed and enlarged cancer research in the DSCSP and Central Coast Regions of California and Statewide that uses regional and statewide CCR data, responded to hundreds of cancer concerns, and has conducted approximately 20 detailed cancer assessments that included formal comparison of the numbers of observed and expected new cancer cases, controlling for the effects of confounding factors, in communities, schools, and workplaces. Consistent with these collaborations and public health need, Dr. Morgan involves approximately a dozen public health students or preventive Medicine Residents in surveillance and research activities in the CCR each year. His current research interests include assessment and isolation of the independent contributions of demographic and quality of care measures in the stage at diagnosis and treatments for breast, colon & rectum, cervix uteri, and pancreas cancer and research that identifies and measures consequences of cancer treatment on development of a second malignancy. While the majority of his current research is in the area of cancer control, Dr. Morgan continues to participate in infectious disease research and infection control that served as his entry into epidemiology.</div>

<div style=" color: rgb(0, 0, 0); font-family: Arial, Helvetica, sans-serif; font-size: 11px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; margin: 0in 0in 0pt; background-color: rgb(255, 255, 255);">            In addition to his continued contributions to education and applied academics at Loma Linda University and his role in cancer control in the CCR, Dr. Morgan served four consecutive two-year terms on the Board of Directors of the California Division of the ACS, a three year term on the Council of the California Breast Cancer Research Program, three terms on the California Division ACS Cancer and the Environment team and continues to serve on the Inland Empire ACS Leadership Council. Dr. Morgan is currently serving a fourth, one-year term on the Institutional Review Board (IRB) of the North American Association of Central Cancer Registries. Since October 2010, Dr. Morgan has Chaired the Cancer Evaluations and Outcomes team of the California ACS and continues service begun in 1995 on the Board of Scientific and Professional Advisors of the American Council on Science and Health (ACSH). In these capacities, Dr. Morgan co-authored the ACSH position papers on risk factors for breast cancer and a white paper on competing causes of death among Americans and has reviewed dozens of ACS reports and publications.</div>

===

John W. Morgan, Dr.PH.

California Cancer Registry

Academic and research epidemiologist with substantial experience in use of population-based cancer surveillance (registry) data in development and evaluation of cancer prevention, control, and treatment strategies.

Current research interests include:

Evaluation of independent roles of demographic variables as predictors of targeted screening, diagnostic stage, and compliance with standards of care for breast and colorectal cancer.

Evaluation of observed and expected counts of new cancer cases in response to concerns about community environmental exposures.

Evaluation of temporal trends in early-stage diagnosis, survival, and mortality for female breast cancer that balance mortality and treatment morbidity consequences.

Establishment of cancer surveillance systems that direct cancer control strategies in underserved segments of the world population.

Specialties:Cancer Epidemiology

Academic Epidemiology

Infectious Disease Epidemiology

Experience

Epidemiologist

California Cancer Registry

1996 – Present (18 years)

Epidemiologist for Region 4 (San Louis Obispo, Santa Barbara, and Ventura Counties) and Region 5 (Inyo, Mono, Riverside, and San Bernardino Counties) with responsibilities for addressing cancer citizens concerns about cancer and utilization of regional and statewide cancer surveillance data for cancer control.

Loma Linda UniversityProfessor

Loma Linda University

1984 – Present (30 years)

Loma Linda UniversityProfessor

Loma Linda University

1983 – Present (31 years)Loma Linda, CA USA

LI fish

Mark Ghamsary

Associate Preofessor and Director of Biostatistics Graduate program at Loma Linda University

Brice Jabo

MSPH-Biostatistics Loma Linda University

Hans Diehl

Founder of CHIP

Nancy Cousineau

Albert Chien

at Southern California Edison

Kyoko Rice

Occupational Therapist at City of Hope

Alana Hudson

Epidemiologist at WV Cancer Registry

Marlon Daniel

Senior Statistician at USDA-ARS

Ann-Marie Rosland, MD MS

Assistant Professor of Medicine, VA Research Scientist

Perfecto Munoz

Senior Policy Advisor on Consumer Health and the Workforce at UC Berkeley SPH/CPAC

---

The Role of Beef in the

American Diet

Prepared for the American Council on Science and Health

by Kathleen Meister, M.S.

Project Coordinator

Ruth Kava, Ph.D., R.D.

Director of Nutrition

President

Elizabeth M. Whelan, Sc.D., M.P.H.

Art Director

Yelena Ponirovskaya

January 2003THE AMERICAN COUNCIL ON SCIENCE AND HEALTH (ACSH) APPRECIATES

THE CONTRIBUTIONS OF THE REVIEWERS NAMED BELOW.

ACSH accepts unrestricted grants on the condition that it is solely responsible for the conduct of

its research and the dissemination of its work to the public. The organization does not perform

proprietary research, nor does it accept support from individual corporations for specific research

projects. All contributions to ACSH—a publicly funded organization under Section 501(c)(3) of

the Internal Revenue Code—are tax deductible.

Individual copies of this report are available at a cost of $5.00. Reduced prices for 10 or more

copies are available upon request.

200three.

Alwynelle S. Ahl, Ph.D., D.V.M,

Tuskegee University

Francis F. Busta, Ph.D.

University of Minnesota

Zerle L. Carpenter, Ph.D.

Texas A&M University

F.J. Francis, Ph.D.

University of Massachusetts, Amherst

Richard A. Greenberg, Ph.D.

Hinsdale, IL

Virgil W. Hays, Ph.D.

University of Kentucky

Manfred Kroger, Ph.D.

The Pennsylvania State University

David Kritchevsky, Ph.D.

The Wistar Institute

William J. Miller, Ph.D.

University of Georgia

Joyce A. Nettleton, D.Sc., R.D.

Denver, CO

Stanley T. Omaye, Ph.D., F.ATS,

F.ACN, C.N.S.

University of Nevada, Reno

Gilbert L. Ross, M.D.

ACSH

Harold H. Sandstead, M.D.

University of Texas Medical Branch,

Galveston

Elizabeth M. Whelan, Sc.D., M.P.H

==